# Octapharma Plasma, Inc. – FDA Inspection, Oct 10, 2018

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8533b922-270b-487b-8b85-0b4f43257066
Source feed: FDA_Inspections

> FDA inspection 1068299 of Octapharma Plasma, Inc., October 10, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068299
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2018-10-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1000479 - 2016-11-16
- FDA Inspection 993051 - 2016-11-16

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/14fd8be2-fd44-4876-89f0-b5cf2d9cfe0c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d